During the past decade, Oizumi Hanawa Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oizumi Hanawa Clinic" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oizumi Hanawa Clinic" are "Atopic Dermatitis" (2 trials), "Psoriasis" (1 trials), "Psoriasis Arthropatica" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Oizumi Hanawa Clinic" in a lesser frequency.

Most popular intervention types in "Oizumi Hanawa Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Apremilast" (1 trials) and "Topical corticosteroid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oizumi Hanawa Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Oizumi Hanawa Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oizumi Hanawa Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oizumi Hanawa Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".